BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 835367)

  • 1. Calcium, phosphate and albumin in serum. A population study with special reference to renal stone formers and the prevalence of hyperparathyroidism in middle-aged men.
    Ljunghall S; Hedstrand H; Hellsing K; Wibell L
    Acta Med Scand; 1977 Jan; 201(1-2):23-30. PubMed ID: 835367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism.
    Parks JH; Coe FL; Evan AP; Worcester EM
    BJU Int; 2009 Mar; 103(5):670-8. PubMed ID: 18793297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hyperparathyroidism in patients with renal stones.
    Sedlack JD; Kenkel J; Czarapata BJ; Paul MG; Pahira JJ; Lee TC
    Surg Gynecol Obstet; 1990 Sep; 171(3):206-8. PubMed ID: 2385813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphate metabolism in renal stone formers. (II): Relation to renal tubular functions and calcium metabolism.
    Wikström B; Backman U; Danielson BG; Fellström B; Johansson G; Ljunghall S; Wide L
    Scand J Urol Nephrol Suppl; 1981; 61():II:1-26. PubMed ID: 6274002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphate metabolism in renal stone formers. (I): Indices of phosphate handling in calcium stone patients and healthy subjects.
    Wikström B; Backman U; Danielson BG; Fellström B; Hellsing K; Johansson G; Ljunghall S
    Scand J Urol Nephrol Suppl; 1981; 61():I:1-18. PubMed ID: 6947410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary hyperparathyroidism: studies of 4,000 urinary calculi patients treated with extracorporeal shockwave lithotripsy].
    Friedrichs R; Behrendt U; Gräf K; Christians T; Borgmann V; Nagel R
    Helv Chir Acta; 1991 Sep; 58(3):327-30. PubMed ID: 1769854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplified protocol for biochemical evaluation of recurrent renal calcium stone disease.
    Thode J; Finnerup B; Parvin C; Holmegaard SN; Skaarup P; Sørensen OH; Transbøl I
    Miner Electrolyte Metab; 1988; 14(5):288-96. PubMed ID: 2845241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphate metabolism and renal calcium stone disease.
    Wikström B
    Scand J Urol Nephrol Suppl; 1981; 61():1-56. PubMed ID: 6274003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effects of parathyroid surgery in normocalcaemic patients with recurrent renal stones.
    Ljunghall S; Källsen R; Backman U; Danielson BG; Grimelius L; Johansson H; Thorén L; Werner I
    Acta Chir Scand; 1980; 146(3):161-9. PubMed ID: 7468037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of bendroflumethiazide on the renal handling of calcium, magnesium and phosphate in normocalcaemic renal stone formers and in hyperparathyroidism.
    Jorgensen FS; Transbol I
    Acta Med Scand; 1973 Oct; 194(4):327-34. PubMed ID: 4749172
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of acute acid loading on acid-base and calcium metabolism.
    Osther PJ
    Scand J Urol Nephrol; 2006; 40(1):35-44. PubMed ID: 16452054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 23 is increased in calcium nephrolithiasis with hypophosphatemia and renal phosphate leak.
    Rendina D; Mossetti G; De Filippo G; Cioffi M; Strazzullo P
    J Clin Endocrinol Metab; 2006 Mar; 91(3):959-63. PubMed ID: 16352682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnosis of parathyroid overactivity in a population of renal stone formers.
    Scott R; Dryburgh F; Wilson R; Boyle IT; Pollock D
    Br J Surg; 1972 Jul; 59(7):517-21. PubMed ID: 5041102
    [No Abstract]   [Full Text] [Related]  

  • 15. Chloride/phosphate ratio in primary hyperparathyroidism.
    Boughey JC; Ewart CJ; Yost MJ; Nottingham JM; Brown JJ
    Am Surg; 2004 Jan; 70(1):25-8. PubMed ID: 14964541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of ionized calcium in the diagnosis of subtle hypercalcemia in symptomatic primary hyperparathyroidism.
    McLeod MK; Monchik JM; Martin HF
    Surgery; 1984 Jun; 95(6):667-73. PubMed ID: 6729704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study.
    Evenepoel P; Claes K; Kuypers D; Maes B; Bammens B; Vanrenterghem Y
    Nephrol Dial Transplant; 2004 May; 19(5):1281-7. PubMed ID: 14993493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case-control study of risk factors for idiopathic calcium nephrolithiasis.
    Wasserstein AG; Stolley PD; Soper KA; Goldfarb S; Maislin G; Agus Z
    Miner Electrolyte Metab; 1987; 13(2):85-95. PubMed ID: 3696092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in the pre-transplant bone-mineral metabolism do not affect the initial progress of the renal graft].
    Rodrigo Calabia E; Ruiz San Millán JC; Gago M; Ruiz Criado J; Piñera Haces C; Fernández Fresnedo G; Palomar R; Gómez Alamillo C; Martín de Francisco AL; Arias M
    Nefrologia; 2009; 29(2):143-9. PubMed ID: 19396320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normocalcemic hyperparathyroidism revisited.
    Poole GV; Albertson DA; Myers RT
    Am Surg; 1983 Dec; 49(12):668-71. PubMed ID: 6546187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.